Back to Authors

Joseph, Richard W.

https://orcid.org/0000-0001-6102-4661

A5034715033 | I1330342723

Mayo Clinic

Citations 86

Molecular analysis of sarcomatoid renal cell carcinoma (sRCC).

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 4556-4556

10.1200/jco.2015.33.15_suppl.4556

Prognostic impact of peripheral blood counts in patients with non-metastatic clear cell renal cell carcinoma.

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e15590-e15590

10.1200/jco.2015.33.15_suppl.e15590

Model-based analysis of the relationship between pembrolizumab (MK-3475) exposure and efficacy in patients with advanced or metastatic melanoma.

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3068-3068

10.1200/jco.2015.33.15_suppl.3068

Atypical patterns of response in patients (pts) with metastatic melanoma treated with pembrolizumab (MK-3475) in KEYNOTE-001.

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3000-3000

10.1200/jco.2015.33.15_suppl.3000

Drug-associated vasculitis occurring after treatment with pembrolizumab

Rheumatology | February 18, 2019 | Volume: 58 | Issue: 8 | Pages: 1501-1503

10.1093/rheumatology/kez051 | PMID 30892627

Desmoplastic melanoma: a brief review and the efficacy of immunotherapy

Expert Review of Anticancer Therapy | January 28, 2019 | Volume: 19 | Issue: 3 | Pages: 205-207

10.1080/14737140.2019.1574573 | PMID 30686076

Loss of BAP1 and PBRM1 expression in non-clear cell renal cell carcinomas compared to clear cell renal cell carcinomas.

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 4529-4529

10.1200/jco.2014.32.15_suppl.4529

A tool to predict post-transcriptional instability related to the dysregulation of the SETD2 histone methyltransferase in renal cell carcinoma (RCC).

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 11072-11072

10.1200/jco.2014.32.15_suppl.11072

Association of loss of BAP1 expression in cell renal cell carcinomas with PDL1 expression.

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 4530-4530

10.1200/jco.2014.32.15_suppl.4530

Baseline tumor size as an independent prognostic factor for overall survival in patients with metastatic melanoma treated with the anti-PD-1 monoclonal antibody MK-3475.

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 3015-3015

10.1200/jco.2014.32.15_suppl.3015